MARIE DILASCIO: Open Payments
NPI 1457851347 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,054 in 115 payments from 19 companies in 2025. Trend: 2023 $1,048 · 2024 $2,645 · 2025 $2,054
Food & beverage: $2,047Education: $7
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $302 |
| Janssen Biotech, Inc. | 19 | $297 |
| UCB, Inc. | 12 | $216 |
| Regeneron Healthcare Solutions, Inc. | 9 | $201 |
| ABBVIE INC. | 11 | $149 |
| Galderma Laboratories, L.P. | 13 | $149 |
| Novartis Pharmaceuticals Corporation | 9 | $137 |
| Lilly USA, LLC | 5 | $109 |
| Biofrontera Inc. | 5 | $100 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
Products named: DUPIXENT, Bimzelx, TREMFYA, SKYRIZI, NEMLUVIO, AXERT, COSENTYX, Sotyktu.
Industry payments across PA — which companies pay providers there.
